Health Catalyst Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Health Catalyst Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
health catalyst公司股票: 对分析师观点的深度剖析 (4个评级)
Throughout the last three months, 4 analysts have evaluated Health Catalyst (NASDAQ:HCAT), offering a diverse set of opinions from bullish to bearish.
在过去的三个月中，4位分析师对Health Catalyst（NASDAQ:HCAT）进行了评估，从看好到看淡提供了各种不同的观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
In the assessment of 12-month price targets, analysts unveil insights for Health Catalyst, presenting an average target of $13.5, a high estimate of $16.00, and a low estimate of $11.00. Marking an increase of 1.28%, the current average surpasses the previous average price target of $13.33.
在12个月的目标价评估中，分析师揭示了Health Catalyst的见解，提供了平均目标价为13.5美元，最高预估为16.00美元，最低预估为11.00美元的评估。目前的平均价格目标为13.33美元，增长了1.28%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析师评级：全面解析
A clear picture of Health Catalyst's perception among...
通过对近期分析师行...
登录免费看全文
登录/注册